Enacts the "ensuring access to behavioral health act"; includes mental health services, substance use disorder treatment services and recovery support services to network adequacy requirements for insurance coverage.
A01792, titled the "ensuring access to behavioral health act," would expand New York’s health plan network adequacy standards to explicitly include mental health services, substance use disorder treatment services, and recovery support services. The bill amends the Public Health Law so that health maintenance organizations must maintain provider networks sufficient to meet enrollees’ comprehensive health needs, including behavioral health care, and specifically references opioid treatment programs and medication-assisted treatment options. It also requires consideration of geographic access, provider availability, and appropriate provider choice when determining whether a network is adequate.
The bill further directs the superintendent of financial services and the commissioner of health to review parity compliance data and national best practices, then update regulations or guidance on network adequacy for behavioral health services. Those updates must include quantitative standards such as travel distance, travel time, appointment wait times, and provider-to-enrollee ratios, along with review of telehealth and telephonic services as supplements to in-person care. The bill also instructs regulators to consider whether networks adequately serve specific populations, including low-income individuals, people with limited English proficiency, LGBTQ individuals, people with disabilities, and children and adults with serious or complex conditions, including co-occurring disorders.
This bill would change New York insurance and managed care oversight by making behavioral health services an explicit part of network adequacy review under the Public Health Law and related regulatory frameworks. It would affect health maintenance organizations, insurers, municipal cooperative health benefit plans, student health plans, and other covered entities by requiring them to demonstrate sufficient access to mental health and substance use disorder providers, including opioid treatment and buprenorphine services. It would also likely prompt updated state regulations or guidance from the Department of Financial Services and the Department of Health, with new measurable standards for access and network sufficiency.
The bill appears generally supportive of expanding access to behavioral health care, with its structure reflecting a policy goal of closing gaps in mental health and addiction treatment access. Because no committee transcript or vote record is provided, there is no direct evidence of formal debate or recorded opposition in the supplied materials. The bill’s language suggests a strong pro-access, pro-parity orientation and a focus on underserved populations and rural access concerns.
The main potential points of contention are likely to be the cost and administrative burden of meeting stricter network adequacy standards, especially the requirement to include all opioid treatment programs and authorized buprenorphine prescribers in every county and New York City. Insurers and managed care plans may also object to prescriptive quantitative standards, expanded regulatory review, and the operational challenges of ensuring adequate behavioral health provider networks in rural or underserved areas. On the other hand, advocates for mental health parity, addiction treatment access, and vulnerable populations would likely support the bill’s stronger access requirements and telehealth provisions.